Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Tenet Healthcare Corporation (NYSE: THC) brings together the company’s official regulatory disclosures, offering a structured view of how this diversified healthcare services organization reports its activities in the general medical and surgical hospitals industry. As a Nevada-incorporated public company with common stock and certain senior notes listed on the New York Stock Exchange, Tenet files a range of documents with the U.S. Securities and Exchange Commission.
Key filings include Form 8-K current reports that describe material events such as quarterly earnings releases, new credit agreements, amendments to letter of credit facilities, and issuances of senior secured first lien notes and senior notes. These filings explain how Tenet structures its debt, the terms of its revolving credit facility and borrowing base, and the use of proceeds from note offerings to redeem or partially redeem existing notes. 8-K reports also cover governance matters like director resignations and adjustments to board size.
Investors can also use this page to access periodic reports such as annual and quarterly filings when available, which provide segment information for the Ambulatory business (United Surgical Partners International) and the Hospital Operations and Services segment, as well as details on Conifer Health Solutions’ revenue cycle and value-based care services. These documents help clarify how Tenet’s hospital, ambulatory and services operations are reflected in its financial statements and risk disclosures.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, such as new debt issuances, covenant terms, or changes in financial outlook. Real-time updates from EDGAR, combined with simplified explanations of complex credit agreements and note indentures, allow users to quickly understand how new filings may relate to Tenet’s capital structure, liquidity, and operational focus.
Tenet Healthcare exec Sun Park had 20,707 restricted stock units (RSUs) convert into common stock on 08/13/2025 after a relocation-based vesting condition was met. The RSUs convert one-for-one into common shares, bringing Park's post-transaction direct beneficial ownership to 23,392 shares. To cover taxes on vesting, 8,813 shares were withheld at an effective value of $171.87 per share, leaving 14,579 shares retained. The RSUs were originally granted on July 17, 2023 under the 2019 Stock Incentive Plan and exercised via standard vesting mechanics.
Saumya Sutaria, CEO and director of Tenet Healthcare Corporation (THC), received a grant of 106,682 shares of common stock that vested as performance-based restricted stock on 08/13/2025. The filing states the award was earned after the Human Resources Committee certified achievement of performance targets for the period January 1, 2021 to June 30, 2025. Following the transaction, Sutaria beneficially owns 475,365 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025.